Coagulation testing plays an integral role in medical diagnostics, particularly when evaluating the hemostatic system of the blood. With the development of technology, today's detection methods have evolved from basic whole blood testing to separated plasma testing. These different detection methods have their own advantages and disadvantages in responding to coagulation conditions.
Coagulation testing is mainly used to diagnose and evaluate the body's hemostasis system, including the functions of platelets, plasma and various coagulation factors. Traditionally, whole blood testing and separated plasma testing are two common testing methods. Whole blood testing can provide information that is closer to the human body's physiological state, while separated plasma testing is easier to operate and preserve in the laboratory.
Whole blood testing considers all blood components and can be initiated immediately, making it extremely valuable in emergency situations. However, this approach also has its challenges, such as difficulties in sample storage and interpretation of results.
Whole blood testing is considered to be the test method that most closely matches the physiological state of the human body, but its interpretation is challenging.
Testing in separated plasma provides more standardized results and can more accurately assess the activity of other coagulation factors without the influence of platelets. In addition, this type of test is easier to store and transport, and is suitable for clinical use in various environments.
Split plasma testing allows for clearer analysis of specific coagulation factors but does not involve overall system coordination.
Coagulation detection methods can be divided into two categories: global detection and local detection.
Global tests, or global coagulation tests, provide an overview of how the entire coagulation system is working and are suitable for initial screening and assessment of the intensity of pathology.
Local testing focuses on detecting the individual components of the coagulation system and can more accurately locate potential pathological changes. For example, D-dimer testing can show the presence of thrombus.
Test methods, such as Activated Partial Thromboplastin Time (APTT) and Prothrombin Time (PT), can not only provide detailed information about the coagulation process, but also help evaluate deeper coagulation factor deficiencies.
Through these specific testing methods, doctors can obtain more detailed information about the patient's coagulation status and formulate corresponding treatment plans.
Although current coagulation testing technology has made significant progress, the medical community still needs to work hard to improve testing accuracy and standardization. Various new technologies and methods have emerged one after another. Will we be able to find a detection method that can better reflect the true coagulation situation in the future?